Levita, Johaina Mae B.

HRN: 26-03-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/16/2024
CEFUROXIME 1.5GM (VIAL)
12/16/2024
12/18/2024
IV
1.5g
Q8h X 4 Doses
SP Primary LTCS
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: